Thomas Watkins is Director of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 0 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Oct 06, 2023, when has been sold 110,447 shares (Ordinary Shares) at a price of $116.5 per share, resulting in proceeds of $12,867,075. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Thomas Watkins Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 06 2023
SELL
Sale (or disposition) back to the issuer
$12,867,075 $116.5 p/Share
110,447 Reduced 100.0%
0 Ordinary Shares
Sep 29 2023
BUY
Exercise of conversion of derivative security
$1,141,774 $14.04 p/Share
81,323 Added 42.41%
110,447 Ordinary Shares
Apr 28 2023
BUY
Exercise of conversion of derivative security
-
3,913 Added 11.84%
29,124 Ordinary Shares
Aug 14 2014
BUY
Open market or private purchase
$58,560 $9.76 p/Share
6,000 Added 50.0%
6,000 Common Stock

Also insider at

VNDA
Vanda Pharmaceuticals Inc. Healthcare
TW

Thomas Watkins

Director
Dublin, L2

Track Institutional and Insider Activities on HZNP

Follow Horizon Therapeutics Public Ltd Co and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HZNP shares.

Notify only if

Insider Trading

Get notified when an Horizon Therapeutics Public LTD CO insider buys or sells HZNP shares.

Notify only if

News

Receive news related to Horizon Therapeutics Public Ltd Co

Track Activities on HZNP